bioRxiv Science⌕ Search

Biology subjects

Resende-Lara, P. T.

Publications and source records attributed to Resende-Lara, P. T..

2 recordsLinked to original sources

Adaptive collective motions: a hybrid method to improve conformational sampling with molecular dynamics and normal modes

Protein function is closely related to its structure and dynamics. Due to its large number of degrees of freedom, proteins adopt a large number of conformations, which describe a highly complex potential energy landscape. Considering the huge ensemble of conformations in dynamic equilibrium in solution, detailed investigation of proteins dynamics is extremely costly. Therefore, a significant number of different methods have emerged in order to improve the conformational sampling of biomolecules. One of these methods is Molecular Dynamics with excited Normal Modes (MDeNM) in which normal modes are used as collective variables in molecular dynamics. Here, we present a new implementation of the MDeNM method that allows a continuously controlled kinetic excitation energy in the normal mode space, while taking into account the natural constraints imposed either by the structure or the environment. These implementations prevent unphysical structural distortions. We tested the new approach on bacteriophages T4 lysozyme, Gallus gallus hen egg-white lysozyme and Staphylococcus aureus membrane-bound transglycosylase. Our results showed that the new approach outperformed free MD sampling and preserved the structural features comparatively to the original MDeNM approach. We also observed that by adaptively changing the excitation direction during calculations, proteins follow new transition paths preventing structural distortions.

biophysics↗

Interfering with MIF-CD74 signalling on macrophages and dendritic cells with a peptide-based approach restores the immune response against metastatic melanoma.

Mounting an effective immune response against cancer requires the activation of innate and adaptive immune cells. Metastatic melanoma is the most aggressive form of skin cancer. Immunotherapies that boost the activity of effector T cells have shown a remarkable success in melanoma treatment. Patients, however, can develop resistance to such therapies by mechanisms that include the establishment of an immune suppressive tumour microenvironment. Understanding how metastatic melanoma cells suppress the immune system is vital to develop effective immunotherapies against this disease. In this study, we find that the innate immune cells, macrophages and dendritic cells are suppressed in metastatic melanoma. The Ig-CDR-based peptide C36L1 is able to restore macrophages and dendritic cells immunogenic functions and to inhibit metastatic growth in vivo. Mechanistically, we found that C36L1 interferes with the MIF-CD74 tumour-innate immune cells immunosuppressive signalling pathway and thereby restores an effective anti-tumour immune response. C36L1 directly binds to CD74 on macrophages and dendritic cells, disturbing CD74 structural dynamics and inhibiting MIF signalling through CD74. Our findings suggest that interfering with MIF-CD74 immunosuppressive signalling in macrophages and dendritic cells using peptide-based immunotherapy can restore the anti-tumour immune response in metastatic melanoma. Our study provides the rationale for further development of peptide-based therapies to restore the anti-tumour immune response.

cancer biology↗